Most Read This Week
- PD-1/PD-L1 Immune Checkpoint Inhibitors for Unresectable Locally Advanced or Metastatic TNBC
- 2024 Top Story in Oncology: Triplet Therapy for HR+/HER2− Metastatic Breast Cancer
- 2024 Top Story in Metastatic Breast Cancer: Epidemiology of Early vs Late Recurrence Among Women With Early-Stage ER+ Breast Cancer
- Efficacy of Everolimus Combined With Hormonal Treatment Following CDK4/6 Inhibitor Therapy
- Assessing the Real-World Effectiveness of Eight Major Metastatic Breast Cancer Drugs Using Target Trial Emulation
Recently Updated
- Assessing the Real-World Effectiveness of Eight Major Metastatic Breast Cancer Drugs Using Target Trial Emulation
- Impact of Molecular Tumor Board Recommendations on Clinical Outcomes in Patients With Metastatic Breast Cancer
- Immune Checkpoint Inhibitors for Patients With Metastatic Inflammatory TNBC
- Effect of RET Overexpression on Brain Metastatic Competency in Luminal Breast Cancer
- Attrition Between Lines of Therapy and Real-World Outcomes in Patients With HER2-Positive Metastatic Breast Cancer